Yale Cancer Center Sponsors Study Of Phenoxodiol For Prostate Cancer

Researchers seek to build on previous study indicating investigational drug phenoxodiol prolonged time to progression and PSA doubling time. (New Haven, Conn., October 22) Yale researchers have begun recruiting 60 men for a clinical trial investigating an experimental new drug, oral phenoxodiol, as a potential first line therapy for prostate cancer.

Autism - The Past, The Present And The Future, Conference, UK

A major conference on the advances in autism research and practice is to be held on June 12th at Prior's Court, one of the country's leading autistic specialist schools near Newbury. This year more children will be diagnosed with autism this year than diabetes, cancer, & AIDS combined.

Combination Therapy Of Solvent-Free Abraxane R And The Targeted Therapy Bevacizumab Evaluated As First-Line Treatment For Metastatic Breast Cancer

Abraxis BioScience, Inc.

3 Basic Principles Could Reduce Incidence Of MRSA In Hospitals

Three basic principles is all it could take to reduce the incidence of MRSA in hospitals according to a new research by Cardiff University.Disinfectants are routinely used on hard surfaces in hospitals to kill bacteria, with antimicrobial containing wipes increasingly being employed for this purpose.

Former Va. Gov. Gilmore Secures Senate GOP Nomination Despite Efforts Of Antiabortion Coalition

Former Virginia Gov. James Gilmore (R) on Saturday secured the Republican nomination for a U.S. Senate seat over Virginia Del. Robert Marshall (R) by 70 votes out of 10, 378 votes cast at the party's state convention, the Washington Post reports.

Bioinvent And Thrombogenics Report Positive Phase I Results For Anti-Plgf Cancer Therapeutic TB-403

BioInvent International AB (OMX Nordic Exchange Stockholm: BINV) and co-development partner ThromboGenics NV (Euronext Brussels: THR) reported that the results from the first Phase l study of novel anti-cancer agent TB-403 showed that it is safe and well tolerated, with pharmacokinetic properties enabling it to be developed for the treatment of cancer.

International HIV AIDS Charity Welcomes New UK Government HIV Strategy But Raises Concerns About Delivery

The International HIV/AIDS Alliance has welcomed the British government's long-term commitment to HIV and to strengthening health systems in developing countries but is questioning whether sufficient funding has been allocated and if the money will actually be spent on HIV services.

132 Members Of Congress Urge One-Year Delay In Controversial Medicare Bidding Program For Home Medical Equipment

Yesterday, nearly one-third of the members of the U.S. House of Representatives urged a one-year delay in the controversial and flawed "competitive bidding" program for home medical equipment in Medicare.

Some Insurers Denying Coverage To Women With Prior C-Sections, New York Times Reports

Some insurers recently have denied individual health coverage to women who have had caesarean sections because such women are likely to undergo the procedure if they become pregnant again, the New York Times reports.

Children In Wales Welcomes Proposals To Ensure Both Parents Register A Child's Birth

Children in Wales welcomes the UK Government White Paper which outlines proposals to make it a legal requirement for both parents to register a child's birth jointly unless it can be shown that this might harm the child in some way. In England and Wales around 7% of births are currently solely registered by the mother, this affects around 45, 000 children every year.